GlassScriptPhysician profile
Jordan A Ridder
NPI 1134648355
$1,775.40
in general payments reported to CMS, 2019-2025
20 companies · $19.67 in 2025
The $19.67 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $153 · 2022: $498 · 2023: $575 · 2024: $529 · 2025: $19.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,006 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,005.79 |
| Education | $118.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $445.15 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $262.92 | 2022-2024 | Ilumya |
| Novartis Pharmaceuticals Corporation | $216.76 | 2022-2023 | |
| E.R. Squibb & Sons, L.L.C. | $188.82 | 2022-2024 | Sotyktu |
| Regeneron Healthcare Solutions, INC. | $152.69 | 2022-2024 | Dupixent |
| Incyte Corporation | $71.69 | 2022-2023 | Opzelura |
| Novo Nordisk INC | $70.11 | 2021-2022 | |
| Leo Pharma INC. | $50.24 | 2023 | Adbry |
| Dermavant Sciences, INC. | $42.19 | 2023-2024 | Vtama |
| Mayne Pharma Commercial LLC | $40.53 | 2023-2024 | |
| Dexcom, INC. | $40.42 | 2021 | |
| Astellas Pharma US INC | $38.23 | 2021-2022 | |
| Pfizer INC. | $33.44 | 2022-2023 | |
| Teleflex LLC | $23.28 | 2022 | |
| Amgen INC. | $18.41 | 2024 | Otezla |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.47 | 2023 | Spevigo |
| Boston Scientific Corporation | $16.85 | 2021 | |
| Arcutis Biotherapeutics, INC. | $16.61 | 2023 | |
| Janssen Biotech, INC. | $15.90 | 2023 | Tremfya |
| Medtronic, INC. | $13.69 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Ridder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.